

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.63097012 |
| 2 | maintenance of protein location in nucleus (GO:0051457) | 7.13929648 |
| 3 | somite rostral/caudal axis specification (GO:0032525) | 6.69283080 |
| 4 | regulation of response to osmotic stress (GO:0047484) | 6.63526235 |
| 5 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.49139998 |
| 6 | negative regulation of epidermis development (GO:0045683) | 6.36707773 |
| 7 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.24476000 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.83574184 |
| 9 | muscle organ morphogenesis (GO:0048644) | 5.83357265 |
| 10 | protein localization to kinetochore (GO:0034501) | 5.73740528 |
| 11 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.68213499 |
| 12 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.62915869 |
| 13 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.59341130 |
| 14 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.57790924 |
| 15 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.53548947 |
| 16 | negative regulation of telomerase activity (GO:0051974) | 5.52773356 |
| 17 | histone H4-K5 acetylation (GO:0043981) | 5.43818494 |
| 18 | histone H4-K8 acetylation (GO:0043982) | 5.43818494 |
| 19 | histone H4-K12 acetylation (GO:0043983) | 5.36728565 |
| 20 | cytidine metabolic process (GO:0046087) | 5.36705412 |
| 21 | cytidine catabolic process (GO:0006216) | 5.36705412 |
| 22 | cytidine deamination (GO:0009972) | 5.36705412 |
| 23 | rRNA transcription (GO:0009303) | 5.28272793 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.23711646 |
| 25 | response to peptidoglycan (GO:0032494) | 5.14176476 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.07998894 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.07998894 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 5.07998894 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 5.07998894 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 5.07998894 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.07998894 |
| 32 | hormone catabolic process (GO:0042447) | 5.05168994 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 5.03546556 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 5.01262198 |
| 35 | phenol-containing compound catabolic process (GO:0019336) | 4.87139024 |
| 36 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.83969331 |
| 37 | regulation of cilium movement (GO:0003352) | 4.77187977 |
| 38 | response to dietary excess (GO:0002021) | 4.75961656 |
| 39 | interferon-gamma production (GO:0032609) | 4.73183429 |
| 40 | notochord development (GO:0030903) | 4.67576460 |
| 41 | heterochromatin organization (GO:0070828) | 4.62636952 |
| 42 | cellular extravasation (GO:0045123) | 4.56152320 |
| 43 | mitotic sister chromatid segregation (GO:0000070) | 4.53043337 |
| 44 | coenzyme catabolic process (GO:0009109) | 4.49194490 |
| 45 | nucleoside transmembrane transport (GO:1901642) | 4.46692348 |
| 46 | primitive streak formation (GO:0090009) | 4.37374233 |
| 47 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.34129054 |
| 48 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.31975811 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 4.28770644 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 4.28746471 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 4.27685346 |
| 52 | rRNA methylation (GO:0031167) | 4.26661861 |
| 53 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.22353289 |
| 54 | quinone metabolic process (GO:1901661) | 4.12546876 |
| 55 | protein localization to chromosome, centromeric region (GO:0071459) | 4.07883509 |
| 56 | negative regulation of telomere maintenance (GO:0032205) | 4.07652388 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 4.06308473 |
| 58 | histone H4-K16 acetylation (GO:0043984) | 4.05448362 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.99266844 |
| 60 | chromatin assembly (GO:0031497) | 3.98118115 |
| 61 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.97239883 |
| 62 | maintenance of protein localization in organelle (GO:0072595) | 3.96352941 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.95683953 |
| 64 | mitochondrion distribution (GO:0048311) | 3.95220094 |
| 65 | regulation of translation in response to stress (GO:0043555) | 3.92341006 |
| 66 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.85085608 |
| 67 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.82985259 |
| 68 | positive regulation of mast cell activation (GO:0033005) | 3.82541887 |
| 69 | detection of other organism (GO:0098543) | 3.81789873 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81191921 |
| 71 | negative regulation of cell killing (GO:0031342) | 3.81191921 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.80849093 |
| 73 | nuclear pore complex assembly (GO:0051292) | 3.79540377 |
| 74 | positive regulation of B cell differentiation (GO:0045579) | 3.79302581 |
| 75 | rRNA modification (GO:0000154) | 3.79135282 |
| 76 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.78876672 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.78783512 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.78783512 |
| 79 | tachykinin receptor signaling pathway (GO:0007217) | 3.78566590 |
| 80 | positive regulation of protein deacetylation (GO:0090312) | 3.77845616 |
| 81 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.76968762 |
| 82 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.76968762 |
| 83 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.71326212 |
| 84 | sister chromatid segregation (GO:0000819) | 3.68807461 |
| 85 | epoxygenase P450 pathway (GO:0019373) | 3.65765126 |
| 86 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.65019080 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.64591665 |
| 88 | retinoic acid receptor signaling pathway (GO:0048384) | 3.63808029 |
| 89 | arachidonic acid secretion (GO:0050482) | 3.63718919 |
| 90 | icosanoid secretion (GO:0032309) | 3.63718919 |
| 91 | vitamin A metabolic process (GO:0006776) | 3.60877484 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 3.59350040 |
| 93 | detection of bacterium (GO:0016045) | 3.58538494 |
| 94 | regulation of mast cell activation (GO:0033003) | 3.55906975 |
| 95 | transepithelial transport (GO:0070633) | 3.55553739 |
| 96 | intestinal epithelial cell development (GO:0060576) | 3.55056590 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 3.55022749 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 3.53423265 |
| 99 | bone trabecula formation (GO:0060346) | 3.52593422 |
| 100 | proline transport (GO:0015824) | 3.50196267 |
| 101 | positive regulation of histone deacetylation (GO:0031065) | 3.49737910 |
| 102 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.46794803 |
| 103 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45688030 |
| 104 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.44067826 |
| 105 | granulocyte activation (GO:0036230) | 3.43850890 |
| 106 | detection of external biotic stimulus (GO:0098581) | 3.43519367 |
| 107 | DNA replication checkpoint (GO:0000076) | 3.43161967 |
| 108 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.40314284 |
| 109 | positive regulation of macrophage cytokine production (GO:0060907) | 3.39604049 |
| 110 | cardiovascular system development (GO:0072358) | 3.38807727 |
| 111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38716422 |
| 112 | RNA stabilization (GO:0043489) | 3.37606797 |
| 113 | mRNA stabilization (GO:0048255) | 3.37606797 |
| 114 | response to host immune response (GO:0052572) | 3.37202313 |
| 115 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37202313 |
| 116 | neutrophil activation (GO:0042119) | 3.33885933 |
| 117 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32431313 |
| 118 | negative regulation of interleukin-2 production (GO:0032703) | 3.31467437 |
| 119 | response to muramyl dipeptide (GO:0032495) | 3.31391880 |
| 120 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.31312580 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31178806 |
| 122 | phagocytosis, recognition (GO:0006910) | 3.30733583 |
| 123 | tolerance induction (GO:0002507) | 3.29737882 |
| 124 | regulation of telomerase activity (GO:0051972) | 3.29643841 |
| 125 | nucleoside transport (GO:0015858) | 3.29390250 |
| 126 | regulation of telomere maintenance (GO:0032204) | 3.28153946 |
| 127 | microtubule severing (GO:0051013) | 3.27521095 |
| 128 | hypotonic response (GO:0006971) | 3.27384327 |
| 129 | germinal center formation (GO:0002467) | 3.26989744 |
| 130 | response to protozoan (GO:0001562) | 3.26429323 |
| 131 | microglial cell activation (GO:0001774) | 3.25148938 |
| 132 | pre-miRNA processing (GO:0031054) | 3.24657454 |
| 133 | macrophage activation (GO:0042116) | 3.23401811 |
| 134 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20715606 |
| 135 | apoptotic DNA fragmentation (GO:0006309) | 3.19289079 |
| 136 | regulation of hypersensitivity (GO:0002883) | 3.18818492 |
| 137 | defense response to protozoan (GO:0042832) | 3.18557612 |
| 138 | maternal placenta development (GO:0001893) | 3.18152557 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17779762 |
| 140 | B cell mediated immunity (GO:0019724) | 3.17486157 |
| 141 | respiratory burst (GO:0045730) | 3.15842820 |
| 142 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.13986525 |
| 143 | nuclear pore organization (GO:0006999) | 3.13890191 |
| 144 | response to thyroid hormone (GO:0097066) | 3.13856329 |
| 145 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13824281 |
| 146 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12545991 |
| 147 | T-helper 1 type immune response (GO:0042088) | 3.11944194 |
| 148 | detection of temperature stimulus (GO:0016048) | 3.11906605 |
| 149 | GDP-mannose metabolic process (GO:0019673) | 3.10253316 |
| 150 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09696765 |
| 151 | ventricular system development (GO:0021591) | 3.09467944 |
| 152 | cofactor transport (GO:0051181) | 3.07580743 |
| 153 | establishment of endothelial barrier (GO:0061028) | 3.07266240 |
| 154 | leukocyte degranulation (GO:0043299) | 3.07249173 |
| 155 | positive regulation of interleukin-17 production (GO:0032740) | 3.05489104 |
| 156 | detection of biotic stimulus (GO:0009595) | 3.04512250 |
| 157 | regulation of antigen processing and presentation (GO:0002577) | 3.03956692 |
| 158 | regulation of microtubule-based movement (GO:0060632) | 3.02546060 |
| 159 | protein polyglutamylation (GO:0018095) | 3.02034340 |
| 160 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.00823581 |
| 161 | trophectodermal cell differentiation (GO:0001829) | 3.00736822 |
| 162 | positive regulation of tissue remodeling (GO:0034105) | 3.00552562 |
| 163 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99278134 |
| 164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98328628 |
| 165 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95264330 |
| 166 | response to host (GO:0075136) | 2.95264330 |
| 167 | response to host defenses (GO:0052200) | 2.95264330 |
| 168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94212858 |
| 169 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90292290 |
| 170 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89878204 |
| 171 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89176821 |
| 172 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88831844 |
| 173 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.87751930 |
| 174 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.85866058 |
| 175 | regulation of regulated secretory pathway (GO:1903305) | 2.85682031 |
| 176 | amino sugar catabolic process (GO:0046348) | 2.84653424 |
| 177 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84355734 |
| 178 | regulation of interferon-alpha production (GO:0032647) | 2.84047299 |
| 179 | regulation of B cell differentiation (GO:0045577) | 2.83901045 |
| 180 | NIK/NF-kappaB signaling (GO:0038061) | 2.82966806 |
| 181 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.79771634 |
| 182 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79600729 |
| 183 | regulation of erythrocyte differentiation (GO:0045646) | 2.77091540 |
| 184 | regulation of interleukin-12 production (GO:0032655) | 2.76095715 |
| 185 | glycosphingolipid catabolic process (GO:0046479) | 2.73980093 |
| 186 | N-acetylneuraminate metabolic process (GO:0006054) | 2.73169205 |
| 187 | neutrophil chemotaxis (GO:0030593) | 2.70590978 |
| 188 | regulation of interleukin-17 production (GO:0032660) | 2.70274094 |
| 189 | myeloid leukocyte activation (GO:0002274) | 2.69931513 |
| 190 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.69855396 |
| 191 | regulation of mononuclear cell migration (GO:0071675) | 2.65230769 |
| 192 | mannose metabolic process (GO:0006013) | 2.64973385 |
| 193 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.64828942 |
| 194 | superoxide anion generation (GO:0042554) | 2.64718622 |
| 195 | oligosaccharide catabolic process (GO:0009313) | 2.63907802 |
| 196 | myeloid dendritic cell activation (GO:0001773) | 2.63745436 |
| 197 | B cell receptor signaling pathway (GO:0050853) | 2.63526546 |
| 198 | daunorubicin metabolic process (GO:0044597) | 11.8277132 |
| 199 | polyketide metabolic process (GO:0030638) | 11.8277132 |
| 200 | doxorubicin metabolic process (GO:0044598) | 11.8277132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.10419914 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.90835403 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.90835403 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.90835403 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.47438276 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 4.77279875 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.09192776 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36145675 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.33271510 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.27775009 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.18305777 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15094706 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.06400492 |
| 14 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.04614914 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.89202911 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.86016570 |
| 17 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.78311875 |
| 18 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.74097560 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73191504 |
| 20 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.72299603 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72263705 |
| 22 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.69704010 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67034490 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.59031946 |
| 25 | GATA1_19941826_ChIP-Seq_K562_Human | 2.58442844 |
| 26 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.53748444 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52928051 |
| 28 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.46361370 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.44174020 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42078909 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31051074 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14611956 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13804511 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11993832 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10618350 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08281089 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07425592 |
| 38 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.02408906 |
| 39 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.01187034 |
| 40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00770135 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99642621 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97915003 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.97171281 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95523612 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95014031 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93053645 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87837835 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.87821176 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86206993 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.85870494 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.85566627 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.83248831 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.80977674 |
| 54 | GATA2_19941826_ChIP-Seq_K562_Human | 1.78642833 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77440104 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.74609572 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.74484795 |
| 58 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.74438333 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74228709 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.73549984 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.72749655 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69983693 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.68361427 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.66343162 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65454867 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64081398 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63943395 |
| 68 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.61516390 |
| 69 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.60818390 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58487744 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55185607 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52568600 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52023299 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49274267 |
| 75 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.48129614 |
| 76 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47913175 |
| 77 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.47488681 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.46020768 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45636707 |
| 80 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45195978 |
| 81 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.45041844 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.43784368 |
| 83 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.41042242 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37653734 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37242247 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36279770 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35760965 |
| 88 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.34943558 |
| 89 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.34870360 |
| 90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34399157 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.33734186 |
| 92 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29192581 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28280701 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28233661 |
| 95 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26703824 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26623964 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25930100 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25583786 |
| 99 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24830182 |
| 100 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.24727333 |
| 101 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24538169 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24012615 |
| 103 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19415163 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18844470 |
| 105 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.18020118 |
| 106 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.17015794 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 1.16946885 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13056577 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11333658 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09356380 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09255983 |
| 112 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08521537 |
| 113 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08404075 |
| 114 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08340605 |
| 115 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08092595 |
| 116 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07779172 |
| 117 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07444503 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05790533 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05468061 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05051238 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03938198 |
| 122 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03813030 |
| 123 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03515541 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03469184 |
| 125 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03209436 |
| 126 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03155899 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03021547 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02916142 |
| 129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02604004 |
| 130 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01796738 |
| 131 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00117292 |
| 132 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97525056 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97376285 |
| 134 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97119951 |
| 135 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96354305 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94653697 |
| 137 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94592666 |
| 138 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92175320 |
| 139 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.92033373 |
| 140 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91333828 |
| 141 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91317645 |
| 142 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91180455 |
| 143 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90062293 |
| 144 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88651043 |
| 145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86056767 |
| 146 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.85906284 |
| 147 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84922549 |
| 148 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.84518388 |
| 149 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.84506736 |
| 150 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.84227939 |
| 151 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82314714 |
| 152 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.81657167 |
| 153 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.81124220 |
| 154 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80508380 |
| 155 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77346760 |
| 156 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77344305 |
| 157 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.77339400 |
| 158 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76748145 |
| 159 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76664058 |
| 160 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76566459 |
| 161 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76073698 |
| 162 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75437625 |
| 163 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.74572270 |
| 164 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.73904838 |
| 165 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.71236399 |
| 166 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.70967637 |
| 167 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70227485 |
| 168 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.69197506 |
| 169 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.68818431 |
| 170 | * STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.67162578 |
| 171 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.65000893 |
| 172 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.64636415 |
| 173 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.64610582 |
| 174 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.63707777 |
| 175 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63586618 |
| 176 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62945954 |
| 177 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62229328 |
| 178 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.60990585 |
| 179 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.60865439 |
| 180 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.60256987 |
| 181 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.59094898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 5.00331197 |
| 2 | MP0002254_reproductive_system_inflammat | 4.96795545 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.55087536 |
| 4 | MP0003303_peritoneal_inflammation | 4.46525590 |
| 5 | MP0006292_abnormal_olfactory_placode | 4.10483987 |
| 6 | MP0004858_abnormal_nervous_system | 3.86181030 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.43500416 |
| 8 | MP0003724_increased_susceptibility_to | 3.35121582 |
| 9 | MP0005499_abnormal_olfactory_system | 3.31480470 |
| 10 | MP0005394_taste/olfaction_phenotype | 3.31480470 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 3.29338817 |
| 12 | MP0002332_abnormal_exercise_endurance | 3.19635284 |
| 13 | MP0001835_abnormal_antigen_presentation | 3.08868925 |
| 14 | MP0005058_abnormal_lysosome_morphology | 3.07762817 |
| 15 | MP0002419_abnormal_innate_immunity | 2.99386118 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.94559881 |
| 17 | MP0003122_maternal_imprinting | 2.94042740 |
| 18 | MP0009785_altered_susceptibility_to | 2.88252785 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.83994725 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.83083131 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.82971704 |
| 22 | MP0005025_abnormal_response_to | 2.62696802 |
| 23 | MP0001790_abnormal_immune_system | 2.57762437 |
| 24 | MP0005387_immune_system_phenotype | 2.57762437 |
| 25 | MP0006082_CNS_inflammation | 2.57061872 |
| 26 | MP0008057_abnormal_DNA_replication | 2.54526241 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.54396951 |
| 28 | MP0005671_abnormal_response_to | 2.51289544 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 2.48293035 |
| 30 | MP0001545_abnormal_hematopoietic_system | 2.48293035 |
| 31 | MP0009278_abnormal_bone_marrow | 2.40411929 |
| 32 | MP0000685_abnormal_immune_system | 2.39944269 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 2.37354896 |
| 34 | MP0009840_abnormal_foam_cell | 2.35746343 |
| 35 | MP0003183_abnormal_peptide_metabolism | 2.31647140 |
| 36 | MP0005464_abnormal_platelet_physiology | 2.29887285 |
| 37 | MP0001800_abnormal_humoral_immune | 2.27376442 |
| 38 | MP0002452_abnormal_antigen_presenting | 2.24152306 |
| 39 | MP0002723_abnormal_immune_serum | 2.22449099 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 2.18357961 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 2.17311203 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 2.13055407 |
| 43 | MP0003121_genomic_imprinting | 2.09134895 |
| 44 | MP0002420_abnormal_adaptive_immunity | 2.07359703 |
| 45 | MP0001819_abnormal_immune_cell | 2.06046706 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.99836611 |
| 47 | MP0009764_decreased_sensitivity_to | 1.96685676 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.94658361 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.92428367 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.88174397 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.81998606 |
| 52 | MP0004147_increased_porphyrin_level | 1.81347742 |
| 53 | MP0003938_abnormal_ear_development | 1.78968040 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.73487895 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.73477817 |
| 56 | MP0005451_abnormal_body_composition | 1.73122361 |
| 57 | MP0005380_embryogenesis_phenotype | 1.64368783 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.64368783 |
| 59 | MP0008469_abnormal_protein_level | 1.64286500 |
| 60 | MP0003075_altered_response_to | 1.64066239 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.62150278 |
| 62 | MP0002398_abnormal_bone_marrow | 1.61696526 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.61525092 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.58058003 |
| 65 | MP0002127_abnormal_cardiovascular_syste | 1.57279626 |
| 66 | MP0008004_abnormal_stomach_pH | 1.56715531 |
| 67 | MP0000716_abnormal_immune_system | 1.56471001 |
| 68 | MP0001849_ear_inflammation | 1.55841651 |
| 69 | MP0003984_embryonic_growth_retardation | 1.54994141 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.52774235 |
| 71 | MP0004510_myositis | 1.48772357 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.48218025 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.47593779 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.47401091 |
| 75 | MP0001293_anophthalmia | 1.43728115 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.42420146 |
| 77 | MP0002092_abnormal_eye_morphology | 1.42322123 |
| 78 | MP0002722_abnormal_immune_system | 1.41107839 |
| 79 | MP0002932_abnormal_joint_morphology | 1.36930203 |
| 80 | MP0000604_amyloidosis | 1.36077105 |
| 81 | MP0002429_abnormal_blood_cell | 1.34872698 |
| 82 | MP0010030_abnormal_orbit_morphology | 1.31334454 |
| 83 | MP0004947_skin_inflammation | 1.30227820 |
| 84 | MP0006054_spinal_hemorrhage | 1.27128597 |
| 85 | MP0000762_abnormal_tongue_morphology | 1.26901633 |
| 86 | MP0001853_heart_inflammation | 1.24485123 |
| 87 | MP0005266_abnormal_metabolism | 1.23589334 |
| 88 | MP0004043_abnormal_pH_regulation | 1.20251908 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 1.19359147 |
| 90 | MP0000350_abnormal_cell_proliferation | 1.18920465 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 1.17303789 |
| 92 | MP0003763_abnormal_thymus_physiology | 1.17119769 |
| 93 | MP0003690_abnormal_glial_cell | 1.17051785 |
| 94 | MP0000049_abnormal_middle_ear | 1.16732811 |
| 95 | MP0003123_paternal_imprinting | 1.10096245 |
| 96 | MP0001348_abnormal_lacrimal_gland | 1.09536355 |
| 97 | MP0002396_abnormal_hematopoietic_system | 1.07786281 |
| 98 | MP0002970_abnormal_white_adipose | 1.07743176 |
| 99 | MP0005248_abnormal_Harderian_gland | 1.07525500 |
| 100 | MP0005166_decreased_susceptibility_to | 1.06617578 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 1.06463665 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 1.06248090 |
| 103 | MP0008260_abnormal_autophagy | 1.05203334 |
| 104 | MP0002233_abnormal_nose_morphology | 1.04963715 |
| 105 | MP0002085_abnormal_embryonic_tissue | 0.99999839 |
| 106 | MP0004381_abnormal_hair_follicle | 0.98812502 |
| 107 | MP0002114_abnormal_axial_skeleton | 0.96842220 |
| 108 | MP0009763_increased_sensitivity_to | 0.96406291 |
| 109 | MP0000432_abnormal_head_morphology | 0.95824422 |
| 110 | MP0005164_abnormal_response_to | 0.94898600 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.94018210 |
| 112 | MP0000428_abnormal_craniofacial_morphol | 0.93375200 |
| 113 | MP0003279_aneurysm | 0.90945256 |
| 114 | MP0008770_decreased_survivor_rate | 0.89240707 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.88985336 |
| 116 | MP0002139_abnormal_hepatobiliary_system | 0.88965370 |
| 117 | MP0005508_abnormal_skeleton_morphology | 0.87350788 |
| 118 | MP0003448_altered_tumor_morphology | 0.85313663 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.84883758 |
| 120 | MP0001663_abnormal_digestive_system | 0.83938821 |
| 121 | MP0003795_abnormal_bone_structure | 0.83429649 |
| 122 | MP0003077_abnormal_cell_cycle | 0.83115309 |
| 123 | MP0005391_vision/eye_phenotype | 0.82969335 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.82840564 |
| 125 | MP0005023_abnormal_wound_healing | 0.82251423 |
| 126 | MP0002084_abnormal_developmental_patter | 0.82131986 |
| 127 | MP0000490_abnormal_crypts_of | 0.82012186 |
| 128 | MP0003755_abnormal_palate_morphology | 0.81623187 |
| 129 | MP0003866_abnormal_defecation | 0.81614450 |
| 130 | MP0002925_abnormal_cardiovascular_devel | 0.80620042 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.80199254 |
| 132 | MP0003283_abnormal_digestive_organ | 0.79238587 |
| 133 | MP0000313_abnormal_cell_death | 0.79085047 |
| 134 | MP0000343_altered_response_to | 0.78130837 |
| 135 | MP0002132_abnormal_respiratory_system | 0.77995281 |
| 136 | MP0003172_abnormal_lysosome_physiology | 0.77720175 |
| 137 | MP0004197_abnormal_fetal_growth/weight/ | 0.76469653 |
| 138 | MP0003828_pulmonary_edema | 0.76354898 |
| 139 | MP0000750_abnormal_muscle_regeneration | 0.76306557 |
| 140 | MP0005390_skeleton_phenotype | 0.74851790 |
| 141 | MP0003119_abnormal_digestive_system | 0.73698399 |
| 142 | MP0000015_abnormal_ear_pigmentation | 0.73055877 |
| 143 | MP0003787_abnormal_imprinting | 0.72327464 |
| 144 | MP0005083_abnormal_biliary_tract | 0.71785084 |
| 145 | MP0001873_stomach_inflammation | 0.71337832 |
| 146 | MP0005197_abnormal_uvea_morphology | 0.71053855 |
| 147 | MP0000749_muscle_degeneration | 0.70174304 |
| 148 | MP0004883_abnormal_blood_vessel | 0.69853951 |
| 149 | MP0004133_heterotaxia | 0.69459714 |
| 150 | MP0000249_abnormal_blood_vessel | 0.65902829 |
| 151 | MP0001851_eye_inflammation | 0.65513082 |
| 152 | MP0002098_abnormal_vibrissa_morphology | 0.65492146 |
| 153 | MP0005647_abnormal_sex_gland | 0.64840775 |
| 154 | MP0003646_muscle_fatigue | 0.64606335 |
| 155 | MP0002138_abnormal_hepatobiliary_system | 0.63355216 |
| 156 | MP0002269_muscular_atrophy | 0.63318615 |
| 157 | MP0005319_abnormal_enzyme/_coenzyme | 0.62652005 |
| 158 | MP0009115_abnormal_fat_cell | 0.62309759 |
| 159 | MP0002116_abnormal_craniofacial_bone | 0.61911317 |
| 160 | MP0005310_abnormal_salivary_gland | 0.60388296 |
| 161 | MP0003436_decreased_susceptibility_to | 0.60345658 |
| 162 | MP0009703_decreased_birth_body | 0.60149054 |
| 163 | MP0003315_abnormal_perineum_morphology | 0.59583760 |
| 164 | MP0000358_abnormal_cell_content/ | 0.58236384 |
| 165 | MP0005174_abnormal_tail_pigmentation | 0.57331387 |
| 166 | MP0001697_abnormal_embryo_size | 0.57221672 |
| 167 | MP0001764_abnormal_homeostasis | 0.57176005 |
| 168 | MP0008874_decreased_physiological_sensi | 0.57048434 |
| 169 | MP0000609_abnormal_liver_physiology | 0.56800196 |
| 170 | MP0002751_abnormal_autonomic_nervous | 0.55658342 |
| 171 | MP0003186_abnormal_redox_activity | 0.55518833 |
| 172 | MP0002080_prenatal_lethality | 0.55140942 |
| 173 | MP0005377_hearing/vestibular/ear_phenot | 0.54764954 |
| 174 | MP0003878_abnormal_ear_physiology | 0.54764954 |
| 175 | MP0004272_abnormal_basement_membrane | 0.52208268 |
| 176 | MP0004782_abnormal_surfactant_physiolog | 0.52092895 |
| 177 | MP0002249_abnormal_larynx_morphology | 0.52073868 |
| 178 | MP0002693_abnormal_pancreas_physiology | 0.51648938 |
| 179 | MP0005623_abnormal_meninges_morphology | 0.50815088 |
| 180 | MP0002405_respiratory_system_inflammati | 0.50327793 |
| 181 | MP0000858_altered_metastatic_potential | 0.50290391 |
| 182 | MP0000377_abnormal_hair_follicle | 0.49969727 |
| 183 | MP0005384_cellular_phenotype | 0.49011290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.66543525 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.45757917 |
| 3 | Hepatoblastoma (HP:0002884) | 5.59106132 |
| 4 | Multiple enchondromatosis (HP:0005701) | 5.28214380 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.25026983 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.23573740 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 5.03775276 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.02747850 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.84209781 |
| 10 | Rib fusion (HP:0000902) | 4.75353751 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 4.55015075 |
| 12 | Stomatitis (HP:0010280) | 4.27701135 |
| 13 | Myositis (HP:0100614) | 4.06656115 |
| 14 | Ependymoma (HP:0002888) | 4.03565568 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.01786646 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.95246594 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.89109989 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.87880215 |
| 19 | Orchitis (HP:0100796) | 3.85370712 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.82802017 |
| 21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.67893071 |
| 22 | Petechiae (HP:0000967) | 3.67542912 |
| 23 | Neoplasm of striated muscle (HP:0009728) | 3.63010092 |
| 24 | Testicular atrophy (HP:0000029) | 3.62756924 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.62661587 |
| 26 | Optic neuritis (HP:0100653) | 3.62661587 |
| 27 | Rectal fistula (HP:0100590) | 3.60442070 |
| 28 | Rectovaginal fistula (HP:0000143) | 3.60442070 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.55177697 |
| 30 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.54413512 |
| 31 | Hypoplasia of the fovea (HP:0007750) | 3.54413512 |
| 32 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.53568428 |
| 33 | Partial duplication of thumb phalanx (HP:0009944) | 3.51071364 |
| 34 | Obstructive lung disease (HP:0006536) | 3.47306357 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47306357 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.42933928 |
| 37 | Fused cervical vertebrae (HP:0002949) | 3.40045529 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.36579692 |
| 39 | Rhabdomyosarcoma (HP:0002859) | 3.33365054 |
| 40 | Loss of speech (HP:0002371) | 3.31981314 |
| 41 | Dysostosis multiplex (HP:0000943) | 3.31016616 |
| 42 | Intestinal fistula (HP:0100819) | 3.28815740 |
| 43 | Embryonal renal neoplasm (HP:0011794) | 3.27940326 |
| 44 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.27767897 |
| 45 | Recurrent skin infections (HP:0001581) | 3.26316840 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20382295 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 3.17832206 |
| 48 | Vaginal fistula (HP:0004320) | 3.14604750 |
| 49 | Mutism (HP:0002300) | 3.14295274 |
| 50 | Hematochezia (HP:0002573) | 3.11912556 |
| 51 | Polycythemia (HP:0001901) | 3.11877842 |
| 52 | Disinhibition (HP:0000734) | 3.11176017 |
| 53 | Increased serum ferritin (HP:0003281) | 3.09677225 |
| 54 | Amyotrophic lateral sclerosis (HP:0007354) | 3.07695317 |
| 55 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.06639177 |
| 56 | Bifid tongue (HP:0010297) | 3.06067799 |
| 57 | Partial duplication of the phalanx of hand (HP:0009999) | 3.04749210 |
| 58 | Abnormality of the salivary glands (HP:0010286) | 3.03997149 |
| 59 | Anomalous pulmonary venous return (HP:0010772) | 3.03992338 |
| 60 | Ragged-red muscle fibers (HP:0003200) | 3.00568456 |
| 61 | Horizontal nystagmus (HP:0000666) | 2.98579474 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.98474053 |
| 63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95168000 |
| 64 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95168000 |
| 65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95168000 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91364618 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91364618 |
| 68 | Abnormality of the astrocytes (HP:0100707) | 2.88650538 |
| 69 | Astrocytoma (HP:0009592) | 2.88650538 |
| 70 | Abnormal cartilage morphology (HP:0002763) | 2.88563259 |
| 71 | Short humerus (HP:0005792) | 2.86917038 |
| 72 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.84882371 |
| 73 | Meningitis (HP:0001287) | 2.81500944 |
| 74 | Recurrent viral infections (HP:0004429) | 2.79425743 |
| 75 | Glomerulonephritis (HP:0000099) | 2.76625500 |
| 76 | Hypochromic anemia (HP:0001931) | 2.76410839 |
| 77 | Gingivitis (HP:0000230) | 2.73938972 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.72870332 |
| 79 | Abnormality of the fovea (HP:0000493) | 2.72282159 |
| 80 | Trismus (HP:0000211) | 2.71388729 |
| 81 | Chromsome breakage (HP:0040012) | 2.70680721 |
| 82 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68576094 |
| 83 | Preauricular pit (HP:0004467) | 2.67351360 |
| 84 | Periauricular skin pits (HP:0100277) | 2.67351360 |
| 85 | Epistaxis (HP:0000421) | 2.65480431 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.64783272 |
| 87 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.63075405 |
| 88 | Large earlobe (HP:0009748) | 2.62865589 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.62562529 |
| 90 | Urticaria (HP:0001025) | 2.62302746 |
| 91 | Abnormal lung lobation (HP:0002101) | 2.60310701 |
| 92 | Abnormality of the pulmonary veins (HP:0011718) | 2.58709388 |
| 93 | Preauricular skin tag (HP:0000384) | 2.57589662 |
| 94 | Purpura (HP:0000979) | 2.57095097 |
| 95 | Encephalitis (HP:0002383) | 2.55605529 |
| 96 | Upper motor neuron abnormality (HP:0002127) | 2.55386506 |
| 97 | Generalized hypotonia (HP:0001290) | 2.54970942 |
| 98 | Vasculitis (HP:0002633) | 2.54513106 |
| 99 | Hemoptysis (HP:0002105) | 2.54295029 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.53919830 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50168637 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50168637 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50168637 |
| 104 | Sensory axonal neuropathy (HP:0003390) | 2.50032844 |
| 105 | Increased connective tissue (HP:0009025) | 2.49858226 |
| 106 | Microcytic anemia (HP:0001935) | 2.49742488 |
| 107 | Hyperventilation (HP:0002883) | 2.47932319 |
| 108 | Thoracic kyphosis (HP:0002942) | 2.46588208 |
| 109 | Pulmonary infiltrates (HP:0002113) | 2.43767447 |
| 110 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.43475396 |
| 111 | Cellulitis (HP:0100658) | 2.43129376 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42962909 |
| 113 | Difficulty running (HP:0009046) | 2.39885922 |
| 114 | Pustule (HP:0200039) | 2.39609981 |
| 115 | Inflammation of the large intestine (HP:0002037) | 2.38858536 |
| 116 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.37854944 |
| 117 | Tetraplegia (HP:0002445) | 2.33914249 |
| 118 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.33211155 |
| 119 | Increased IgE level (HP:0003212) | 2.29105242 |
| 120 | Shawl scrotum (HP:0000049) | 2.28409871 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 2.28301172 |
| 122 | Colitis (HP:0002583) | 2.27762873 |
| 123 | Skin tags (HP:0010609) | 2.27723830 |
| 124 | Nasolacrimal duct obstruction (HP:0000579) | 2.27384810 |
| 125 | Hand muscle atrophy (HP:0009130) | 2.27203170 |
| 126 | Neoplasm of the heart (HP:0100544) | 2.26452692 |
| 127 | Cheilitis (HP:0100825) | 2.26061458 |
| 128 | Pendular nystagmus (HP:0012043) | 2.24753029 |
| 129 | Villous atrophy (HP:0011473) | 2.24242625 |
| 130 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.24242625 |
| 131 | Leukocytosis (HP:0001974) | 2.23608435 |
| 132 | Hypopigmentation of the fundus (HP:0007894) | 2.23267621 |
| 133 | Nasal polyposis (HP:0100582) | 2.22540804 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22355928 |
| 135 | Mucopolysacchariduria (HP:0008155) | 2.22355928 |
| 136 | Abnormality of the musculature of the hand (HP:0001421) | 2.22212784 |
| 137 | Osteomyelitis (HP:0002754) | 2.21796146 |
| 138 | Hepatosplenomegaly (HP:0001433) | 2.19070348 |
| 139 | Gastrointestinal infarctions (HP:0005244) | 2.19012534 |
| 140 | Short 5th finger (HP:0009237) | 2.18790358 |
| 141 | Abnormality of chromosome segregation (HP:0002916) | 2.18173404 |
| 142 | Progressive muscle weakness (HP:0003323) | 2.18075661 |
| 143 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17511313 |
| 144 | Abnormality of the pubic bones (HP:0003172) | 2.16534799 |
| 145 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.13955997 |
| 146 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13230392 |
| 147 | Tongue fasciculations (HP:0001308) | 2.13098474 |
| 148 | Impulsivity (HP:0100710) | 2.12389803 |
| 149 | Esophageal neoplasm (HP:0100751) | 2.10247019 |
| 150 | Neoplasm of head and neck (HP:0012288) | 2.10247019 |
| 151 | Polyneuropathy (HP:0001271) | 2.07815741 |
| 152 | Skin pits (HP:0100276) | 2.05684940 |
| 153 | Panhypogammaglobulinemia (HP:0003139) | 2.04946244 |
| 154 | Reticulocytosis (HP:0001923) | 2.04873493 |
| 155 | Skin nodule (HP:0200036) | 2.04379029 |
| 156 | Glioma (HP:0009733) | 2.04342486 |
| 157 | Meckel diverticulum (HP:0002245) | 2.04100230 |
| 158 | Pseudobulbar signs (HP:0002200) | 2.03846693 |
| 159 | Peritonitis (HP:0002586) | 2.03062661 |
| 160 | Amyloidosis (HP:0011034) | 2.02512465 |
| 161 | Renal duplication (HP:0000075) | 2.02012117 |
| 162 | Spastic tetraparesis (HP:0001285) | 2.01976257 |
| 163 | Episodic fever (HP:0001954) | 2.01204049 |
| 164 | Gastrointestinal stroma tumor (HP:0100723) | 2.00792041 |
| 165 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00207880 |
| 166 | Anorexia (HP:0002039) | 1.99708688 |
| 167 | Paralysis (HP:0003470) | 1.99693997 |
| 168 | Achilles tendon contracture (HP:0001771) | 1.99622613 |
| 169 | Abnormal platelet function (HP:0011869) | 1.99425167 |
| 170 | Impaired platelet aggregation (HP:0003540) | 1.99425167 |
| 171 | Supernumerary nipples (HP:0002558) | 1.98836754 |
| 172 | Myocardial infarction (HP:0001658) | 1.98663654 |
| 173 | Conjunctival telangiectasia (HP:0000524) | 1.98516736 |
| 174 | Gingival bleeding (HP:0000225) | 1.97844039 |
| 175 | Combined immunodeficiency (HP:0005387) | 1.96953132 |
| 176 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.96755614 |
| 177 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.96404923 |
| 178 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.96197289 |
| 179 | Arterial thrombosis (HP:0004420) | 1.95703599 |
| 180 | Fasciculations (HP:0002380) | 1.95333444 |
| 181 | Albinism (HP:0001022) | 1.94936434 |
| 182 | Muscle fibrillation (HP:0010546) | 1.93606525 |
| 183 | Upper limb muscle weakness (HP:0003484) | 1.93103267 |
| 184 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.92710994 |
| 185 | Abnormality of the periventricular white matter (HP:0002518) | 1.92528220 |
| 186 | Vertigo (HP:0002321) | 1.92103503 |
| 187 | Abnormal hemoglobin (HP:0011902) | 1.91899916 |
| 188 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.91686975 |
| 189 | Hypoplastic scapulae (HP:0000882) | 1.91686975 |
| 190 | T lymphocytopenia (HP:0005403) | 1.91599594 |
| 191 | Vertebral fusion (HP:0002948) | 1.91235438 |
| 192 | Progressive neurologic deterioration (HP:0002344) | 1.90242586 |
| 193 | Restrictive lung disease (HP:0002091) | 1.89956083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.29111768 |
| 2 | GRK5 | 5.58863109 |
| 3 | ERN1 | 4.95327802 |
| 4 | GRK6 | 4.41789977 |
| 5 | ADRBK2 | 3.37410437 |
| 6 | TGFBR2 | 3.32126346 |
| 7 | GRK1 | 3.28515173 |
| 8 | CSF1R | 3.26397738 |
| 9 | MAP4K1 | 3.10770582 |
| 10 | GRK7 | 2.81310092 |
| 11 | MAP2K3 | 2.56890068 |
| 12 | TYRO3 | 2.55920530 |
| 13 | TYK2 | 2.54341845 |
| 14 | MATK | 2.47090966 |
| 15 | JAK3 | 2.43581222 |
| 16 | MAP3K13 | 2.34938503 |
| 17 | MAPK7 | 2.33310052 |
| 18 | ZAP70 | 2.29213838 |
| 19 | STK10 | 2.26361846 |
| 20 | MOS | 2.21108874 |
| 21 | IRAK4 | 2.20938657 |
| 22 | TTK | 2.19874194 |
| 23 | MAP3K14 | 2.18354498 |
| 24 | FES | 2.12752820 |
| 25 | NME2 | 2.05535393 |
| 26 | WNK1 | 1.98507499 |
| 27 | IRAK3 | 1.96204086 |
| 28 | SYK | 1.82564478 |
| 29 | TBK1 | 1.78906733 |
| 30 | BTK | 1.70960528 |
| 31 | TAOK2 | 1.67972831 |
| 32 | TNK2 | 1.66711228 |
| 33 | TXK | 1.65874299 |
| 34 | MAP3K11 | 1.64720178 |
| 35 | NTRK1 | 1.61982581 |
| 36 | TAOK1 | 1.60896977 |
| 37 | CAMK4 | 1.49518784 |
| 38 | PRKG2 | 1.46484494 |
| 39 | MARK3 | 1.45873607 |
| 40 | MAP3K3 | 1.45835899 |
| 41 | LYN | 1.44332887 |
| 42 | IKBKE | 1.44212696 |
| 43 | TEC | 1.33279908 |
| 44 | MAP3K1 | 1.30009990 |
| 45 | PAK4 | 1.28696901 |
| 46 | CDK7 | 1.26516401 |
| 47 | MARK2 | 1.23979264 |
| 48 | FGFR3 | 1.16201649 |
| 49 | MAP2K4 | 1.14295826 |
| 50 | MAP3K10 | 1.12073446 |
| 51 | ADRBK1 | 1.10705470 |
| 52 | LCK | 1.09475961 |
| 53 | HIPK2 | 1.09390269 |
| 54 | CDC42BPA | 1.06964156 |
| 55 | CSK | 1.02181302 |
| 56 | TIE1 | 1.02113552 |
| 57 | EPHA2 | 1.00676502 |
| 58 | CHEK2 | 0.94165533 |
| 59 | AKT3 | 0.90711951 |
| 60 | DAPK2 | 0.81181082 |
| 61 | TAOK3 | 0.78362074 |
| 62 | JAK1 | 0.77286477 |
| 63 | PASK | 0.74656172 |
| 64 | PLK1 | 0.73443400 |
| 65 | KSR2 | 0.71868015 |
| 66 | CLK1 | 0.71579185 |
| 67 | MAP2K6 | 0.70267997 |
| 68 | MAPK12 | 0.69702193 |
| 69 | BLK | 0.68936367 |
| 70 | RPS6KC1 | 0.68738141 |
| 71 | RPS6KL1 | 0.68738141 |
| 72 | MAP3K7 | 0.67906304 |
| 73 | BMPR2 | 0.67110094 |
| 74 | ALK | 0.66004624 |
| 75 | AKT2 | 0.65008214 |
| 76 | TGFBR1 | 0.63712661 |
| 77 | PDPK1 | 0.62027803 |
| 78 | EIF2AK2 | 0.61109171 |
| 79 | PRKCQ | 0.60903024 |
| 80 | RPS6KA6 | 0.60007208 |
| 81 | CAMKK2 | 0.58313352 |
| 82 | PTK6 | 0.56576652 |
| 83 | PIM1 | 0.55054670 |
| 84 | BMX | 0.54382553 |
| 85 | RIPK1 | 0.53947501 |
| 86 | ACVR1B | 0.53200840 |
| 87 | CHEK1 | 0.52631904 |
| 88 | MAP3K9 | 0.50522093 |
| 89 | CAMKK1 | 0.50423707 |
| 90 | MAP3K5 | 0.49803779 |
| 91 | IGF1R | 0.49495451 |
| 92 | IKBKB | 0.47908528 |
| 93 | IRAK2 | 0.46866847 |
| 94 | MTOR | 0.46797815 |
| 95 | MAP3K8 | 0.46476019 |
| 96 | IRAK1 | 0.46280083 |
| 97 | PDK2 | 0.45557421 |
| 98 | LATS2 | 0.45024689 |
| 99 | PINK1 | 0.43471023 |
| 100 | PIK3CG | 0.42361223 |
| 101 | TRPM7 | 0.41719865 |
| 102 | PTK2B | 0.41247540 |
| 103 | MAP3K6 | 0.39890961 |
| 104 | PTK2 | 0.39884396 |
| 105 | PRKCD | 0.39780346 |
| 106 | ABL2 | 0.39651306 |
| 107 | ITK | 0.39530840 |
| 108 | STK11 | 0.36364395 |
| 109 | PDGFRA | 0.35220231 |
| 110 | ERBB2 | 0.34369981 |
| 111 | TAF1 | 0.33403127 |
| 112 | RPS6KA2 | 0.31081110 |
| 113 | MAP3K2 | 0.30290245 |
| 114 | CDK2 | 0.29830789 |
| 115 | CDK6 | 0.29347378 |
| 116 | INSR | 0.29249082 |
| 117 | TRIB3 | 0.28731012 |
| 118 | PIM2 | 0.27769722 |
| 119 | GSK3A | 0.25691493 |
| 120 | SIK1 | 0.25589053 |
| 121 | MAPK10 | 0.24562290 |
| 122 | PRKCI | 0.23182876 |
| 123 | CDK4 | 0.22978169 |
| 124 | STK38 | 0.22957380 |
| 125 | DDR2 | 0.21900310 |
| 126 | SIK2 | 0.21863232 |
| 127 | KIT | 0.20831267 |
| 128 | PAK1 | 0.20534624 |
| 129 | CHUK | 0.20012889 |
| 130 | PRKACG | 0.19684773 |
| 131 | MAPK4 | 0.19619466 |
| 132 | NEK2 | 0.18339418 |
| 133 | ATM | 0.18041265 |
| 134 | MAPK1 | 0.18000685 |
| 135 | ICK | 0.17962330 |
| 136 | HCK | 0.16201715 |
| 137 | CSNK1E | 0.15758024 |
| 138 | PRPF4B | 0.15671651 |
| 139 | PRKD2 | 0.15274301 |
| 140 | AURKA | 0.13465486 |
| 141 | EGFR | 0.13381962 |
| 142 | PRKAA1 | 0.12952238 |
| 143 | GSK3B | 0.12900863 |
| 144 | JAK2 | 0.12635765 |
| 145 | MAPK14 | 0.12532707 |
| 146 | PRKACB | 0.12271770 |
| 147 | CAMK1D | 0.11966489 |
| 148 | RIPK4 | 0.11871223 |
| 149 | CDK1 | 0.11357460 |
| 150 | FGR | 0.11352733 |
| 151 | DYRK1B | 0.09906696 |
| 152 | MAPKAPK2 | 0.09605813 |
| 153 | MET | 0.09118226 |
| 154 | CDK15 | 0.09097881 |
| 155 | DYRK1A | 0.09030073 |
| 156 | RPS6KB2 | 0.08047328 |
| 157 | RPS6KA3 | 0.07765034 |
| 158 | ABL1 | 0.07547618 |
| 159 | PDK1 | 0.07218989 |
| 160 | SRC | 0.07026722 |
| 161 | PRKACA | 0.06933237 |
| 162 | PAK3 | 0.06228623 |
| 163 | CDK11A | 0.06188361 |
| 164 | CDC7 | 0.05405591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.86612860 |
| 2 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.18577392 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.33222327 |
| 4 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.09282911 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.98016031 |
| 6 | * Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.96476106 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.94528690 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.49627086 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.45138762 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.31029855 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.29675154 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29547122 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.29237727 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.26981924 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.26094765 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12341623 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11825707 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 2.10875093 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09781204 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03843159 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02627538 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96642674 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.92105167 |
| 24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.81166421 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.73811778 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66226626 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.62807964 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60476236 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59379329 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59140387 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55058195 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48980011 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48380177 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37333485 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35731096 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32063779 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28624264 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.24427696 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.21680882 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21625642 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21528978 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18757812 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16919924 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15159332 |
| 45 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.12788712 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12240963 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10548649 |
| 48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.10000008 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.07207446 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.05291520 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.04135517 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.03636686 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01741916 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.97400513 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95797758 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93630160 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91600545 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91123497 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89611720 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89255029 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87980997 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86926606 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84420062 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84406732 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84325127 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 0.81714103 |
| 67 | Pathways in cancer_Homo sapiens_hsa05200 | 0.79960493 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77367211 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75724749 |
| 70 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75254247 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72792009 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71445621 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71441518 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70907613 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70867614 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70811492 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70603331 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70347568 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.70171611 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69413364 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.68464007 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67090074 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64447333 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64003740 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63559994 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.62351489 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61403398 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60094823 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58998623 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58968992 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56679446 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.55128847 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.53809890 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53324929 |
| 95 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53067753 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52972356 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52950873 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52130595 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52109002 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51756021 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51169201 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50019240 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48274649 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47988408 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46650098 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.45941687 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.45836914 |
| 108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45742104 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.45675486 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.43960426 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43755315 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43555540 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43235918 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.40941013 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40585295 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40514428 |
| 117 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39049343 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37399700 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37084738 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36882827 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36547855 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.36470608 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36011136 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35696808 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35280456 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34541665 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.34400282 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.34258177 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34176884 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34068214 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32935502 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.32609438 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32316679 |
| 134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30554094 |
| 135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28808987 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27871493 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.27475153 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.26710098 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26649062 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26570372 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25917389 |
| 142 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.24864607 |
| 143 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24847025 |
| 144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24616410 |
| 145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24000211 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.22924996 |
| 147 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.22678589 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.22428802 |
| 149 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21601931 |
| 150 | Taste transduction_Homo sapiens_hsa04742 | 0.21123067 |
| 151 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.21120219 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20348698 |

